Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
tamatinib proto-oncogene c-ret NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA clinical trial unknown
tamatinib proto-oncogene c-ret NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.01 clinical trial unknown
tamatinib proto-oncogene c-ret NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA clinical trial inhibitor
tamatinib tyrosine-protein kinase syk small molecule Successful target TTD , drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.1 experimental,investigational,clinical trial unknown
tamatinib tyrosine-protein kinase syk small molecule Successful target TTD , drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA experimental,investigational,clinical trial unknown
tamatinib tyrosine-protein kinase syk small molecule Successful target TTD , drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 0.1 experimental,investigational,clinical trial inhibitor
tamatinib tyrosine-protein kinase syk small molecule Successful target TTD , drugbank , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]		 NA experimental,investigational,clinical trial inhibitor
click here to return to the previous page